Laurion Capital Management LP Absci Corp Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $3.66 Million - $6.16 Million	1,072,573 Added 942.06%	1,186,427 $6.74 Million
Q4 2023 Feb 14, 2024	BUY	$1.15 - $4.79 $130,932 - $545,360	113,854 New	113,854 $478,000
Q1 2022 May 16, 2022	SELL	$5.87 - $9.46 $587,000 - $946,000	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.37 - $30.29 $1.04 Million - $3.03 Million	100,000 New	100,000 $1.16 Million

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $249M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.